BMC Oral Health. 2026 Aug 24;26(1):2315. doi: 10.1186/s12903-026-09616-5.
ABSTRACT
OBJECTIVES: The objective of this study was to compare and evaluate the effects of concentrated growth factor (CGF) and advanced platelet-rich fibrin (A-PRF) clot membranes on palatal epithelial wound healing and postoperative discomfort following free gingival graft (FGG) harvesting.
MATERIALS AND METHODS: Forty-five patients who underwent FGG harvesting were randomly allocated into three groups: (1) control group (n = 15), receiving only a sterile gelatin sponge; (2) A-PRF group (n = 15), receiving A-PRF clot membranes; and (3) CGF group (n = 15), receiving CGF clot membranes at the donor site. The epithelization rate, color match, and sensation scores of the palatal wound were assessed at 1, 2, 3, and 4 weeks postoperatively. Pain levels, analgesic consumption, and bleeding time were self-reported by patients for the first 7 days of healing.
RESULTS: No significant differences in epithelialization and sensitivity scores were observed among the groups at any time point (P>.05). Palatal color matching was superior in the A-PRF and CGF groups compared to the control group at 1 and 2 weeks (P<.05). Visual analog scale (VAS) pain scores and the number of analgesic tablets consumed were lower in the CGF group than in the control group on days 2, 3, 4, and 5 (P<.05). At 14 days, VAS pain scores were significantly lower in both the A-PRF and CGF groups compared to the control group (P<.05). Immediate bleeding time at the donor site was significantly reduced in the A-PRF and CGF groups compared to the control group (P<.05), while no significant differences were found among the groups regarding late bleeding at 7 days postoperatively (P>.05).
CONCLUSIONS: Although CGF demonstrated a slight advantage over A-PRF membranes, the findings indicate that neither CGF nor A-PRF accelerates epithelialization or palatal wound healing. However, the benefits of A-PRF and CGF appear to be mainly limited to postoperative comfort and immediate hemostasis rather than acceleration of epithelialization or sensory recovery.
CLINICAL RELEVANCE: Application of A-PRF and CGF may reduce immediate bleeding and postoperative pain following FGG harvesting.
TRIAL REGISTRATION: ClinicalTrials.gov NCT07439068, registered on 10 February 2026. (Retrospectively registered).
PMID:43052952 | DOI:10.1186/s12903-026-09616-5
